Christina Weiler‐Normann

3.5k total citations
57 papers, 1.7k citations indexed

About

Christina Weiler‐Normann is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Christina Weiler‐Normann has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 37 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Christina Weiler‐Normann's work include Liver Diseases and Immunity (43 papers), Liver Disease Diagnosis and Treatment (34 papers) and Hepatitis B Virus Studies (13 papers). Christina Weiler‐Normann is often cited by papers focused on Liver Diseases and Immunity (43 papers), Liver Disease Diagnosis and Treatment (34 papers) and Hepatitis B Virus Studies (13 papers). Christina Weiler‐Normann collaborates with scholars based in Germany, United Kingdom and Netherlands. Christina Weiler‐Normann's co-authors include Christoph Schramm, Ansgar W. Lohse, Marcial Sebode, Johannes Herkel, Moritz Peiseler, Christiane Wiegard, Alexander Quaas, Johannes Hartl, Roman Zenouzi and Nadine Pannicke and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Hepatology.

In The Last Decade

Christina Weiler‐Normann

54 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Weiler‐Normann Germany 22 1.4k 1.2k 374 256 180 57 1.7k
Christian M. Lange Germany 17 746 0.6× 736 0.6× 364 1.0× 118 0.5× 86 0.5× 51 1.5k
Zoe Mariñó Spain 21 2.1k 1.5× 1.9k 1.6× 160 0.4× 121 0.5× 98 0.5× 90 2.5k
Emanuel K. Manesis Greece 33 2.3k 1.7× 2.5k 2.2× 185 0.5× 116 0.5× 73 0.4× 80 3.0k
Ching‐Sheng Hsu Taiwan 24 1.1k 0.8× 1.1k 1.0× 248 0.7× 146 0.6× 95 0.5× 70 1.8k
Nir Hilzenrat Canada 16 693 0.5× 596 0.5× 214 0.6× 112 0.4× 40 0.2× 56 1.1k
J. Moussalli France 24 2.3k 1.7× 2.3k 2.0× 105 0.3× 126 0.5× 51 0.3× 56 2.7k
Matteo Rosselli Italy 18 441 0.3× 1.3k 1.1× 526 1.4× 46 0.2× 165 0.9× 35 1.8k
Fulya Günşar Türkiye 20 794 0.6× 788 0.7× 589 1.6× 41 0.2× 81 0.5× 91 1.5k
Santiago Tomé Spain 18 539 0.4× 578 0.5× 259 0.7× 38 0.1× 53 0.3× 51 1.2k
Ned Snyder United States 20 401 0.3× 534 0.5× 365 1.0× 49 0.2× 50 0.3× 38 1.1k

Countries citing papers authored by Christina Weiler‐Normann

Since Specialization
Citations

This map shows the geographic impact of Christina Weiler‐Normann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Weiler‐Normann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Weiler‐Normann more than expected).

Fields of papers citing papers by Christina Weiler‐Normann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Weiler‐Normann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Weiler‐Normann. The network helps show where Christina Weiler‐Normann may publish in the future.

Co-authorship network of co-authors of Christina Weiler‐Normann

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Weiler‐Normann. A scholar is included among the top collaborators of Christina Weiler‐Normann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Weiler‐Normann. Christina Weiler‐Normann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stockdale, Alexander, Benno Kreuels, Isaac Thom Shawa, et al.. (2025). Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case–control study. The Lancet Global Health. 13(11). e1924–e1934.
2.
Hartl, Johannes, Malte H. Wehmeyer, Marcial Sebode, et al.. (2023). Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis. Liver International. 43(6). 1269–1276. 6 indexed citations
3.
Uhlenbusch, Natalie, Christina Weiler‐Normann, Theresia Herget, et al.. (2023). Psychological distress of adult patients consulting a center for rare and undiagnosed diseases: a cross-sectional study. Orphanet Journal of Rare Diseases. 18(1). 82–82. 6 indexed citations
4.
Hartl, Johannes, Thomas Theo Brehm, Fabian Glaser, et al.. (2022). SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease. United European Gastroenterology Journal. 10(3). 319–329. 23 indexed citations
5.
Hartl, Johannes, Martina Sterneck, Marcial Sebode, et al.. (2022). Low antibody titers after second SARS-CoV-2 vaccination in patients with autoimmune hepatitis. Zeitschrift für Gastroenterologie. 60(1). e24–e24.
6.
Hartl, Johannes, Rosa Miquel, Kalliopi Zachou, et al.. (2020). Features and outcome of AIH patients without elevation of IgG. JHEP Reports. 2(3). 100094–100094. 34 indexed citations
7.
Weiler‐Normann, Christina & Ansgar W. Lohse. (2020). Autoimmune hepatitis: from immunopathogenesis to diagnostic and therapeutic innovation. Current Opinion in Gastroenterology. 37(2). 86–90. 7 indexed citations
8.
Uhlenbusch, Natalie, Bernd Löwe, Martin Härter, et al.. (2019). Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study. PLoS ONE. 14(2). e0211343–e0211343. 67 indexed citations
9.
Schramm, Christoph, Florian Brinkert, Sören Weidemann, et al.. (2018). Immunosuppression as effective therapy for eosinophilic cholangiopathy: A case series and review of the literature. 1(1). 33–44. 1 indexed citations
10.
Weiler‐Normann, Christina, Johannes Hartl, Sören Weidemann, et al.. (2018). Acute hepatitis as a prequel to very severe aplastic anemia. Zeitschrift für Gastroenterologie. 56(1). 51–54. 3 indexed citations
11.
Lohse, Ansgar W., Johannes Herkel, & Christina Weiler‐Normann. (2017). Can Understanding the Pathogenesis of Autoimmune Hepatitis Lead to Rational Therapy?. Digestive Diseases. 35(4). 367–370. 6 indexed citations
12.
Peiseler, Moritz, Marcial Sebode, Roman Zenouzi, et al.. (2017). Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology. 16(2). 260–267.e1. 42 indexed citations
13.
Hartl, Johannes, U Denzer, Hanno Ehlken, et al.. (2016). Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis. Journal of Hepatology. 65(4). 769–775. 121 indexed citations
14.
Weiler‐Normann, Christina & Ansgar W. Lohse. (2016). Variant Syndromes of Autoimmune Liver Diseases: Classification, Diagnosis and Management. Digestive Diseases. 34(4). 334–339. 12 indexed citations
15.
Schoknecht, Tanja, Dorothee Schwinge, Stephanie Stein, et al.. (2016). CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood. Journal of Leukocyte Biology. 101(2). 589–597. 15 indexed citations
16.
Löbel, Ulrike, Nils D. Forkert, Peter Schmitt, et al.. (2016). Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR Angiography. PLoS ONE. 11(11). e0164863–e0164863. 2 indexed citations
17.
Sebode, Marcial, Moritz Peiseler, Dorothee Schwinge, et al.. (2014). Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. Journal of Hepatology. 60(5). 1010–1016. 84 indexed citations
18.
Hartl, Johannes, Hanno Ehlken, Christina Weiler‐Normann, et al.. (2014). Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis. Journal of Hepatology. 62(3). 642–646. 68 indexed citations
19.
Weiler‐Normann, Christina, Christoph Schramm, Alexander Quaas, et al.. (2012). Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. Journal of Hepatology. 58(3). 529–534. 159 indexed citations
20.
Mizukoshi, Eishiro, Christoph Eisenbach, Brian R. Edlin, et al.. (2008). Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV. The Journal of Infectious Diseases. 198(2). 203–212. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian M. Lange Breakdown of academic impact, for papers by Zoe Mariñó Breakdown of academic impact, for papers by Emanuel K. Manesis Breakdown of academic impact, for papers by Ching‐Sheng Hsu Breakdown of academic impact, for papers by Nir Hilzenrat Breakdown of academic impact, for papers by J. Moussalli Breakdown of academic impact, for papers by Matteo Rosselli Breakdown of academic impact, for papers by Fulya Günşar Breakdown of academic impact, for papers by Santiago Tomé Breakdown of academic impact, for papers by Ned Snyder
Rankless by CCL
2026